Author: Mark Newman
An Appetite for Research: Q&A with Eleftheria Maratos-Flier, MD
House Science, Space, and Technology Committee Discusses Research Relief Legislation
On September 9, the House Science, Space, and Technology Committee conducted a hearing about “The Impact of the COVID-19 Crisis on University Research.” While delivering their opening remarks, Haley Stevens (D-MI), chairwoman of the Subcommittee on Research and Technology, and Eddie Bernice Johnson (D-TX), chairwoman of the full Committee, spoke about the financial pressures facing...
Endocrine Society Members Rally (Online) for Medical Research
COVID-19 and Subacute Thyroiditis: An Alert for Endocrinologists
A paper published in The Journal of Clinical Endocrinology & Metabolism sounds an alarm for clinicians treating COVID-19 patients to be on the lookout for possible cases of subacute thyroiditis post-infection. COVID-19 upended the world as we knew it in 2020, and its effects are continuing to be felt. New clinical sequelae are also emerging,...
Agency and industry must evaluate cumulative health effects of classes of related food chemicals. Today, a group of health, environmental, and consumer organizations challenged the Food and Drug Administration’s (FDA) practice of not accounting for the cumulative health effect of chemicals in the diet when allowing new chemicals in food. Over 60 years ago, Congress passed a law requiring that FDA and industry do just that. Unfortunately, an Environmental Defense Fund (EDF) investigation of nearly 900 safety determinations found that only one considered the requirement in a meaningful way....
The American Board of Internal Medicine (ABIM) Endocrinology, Diabetes, and Metabolism Board is looking for an endocrinologist practicing in a private/community setting whose term would begin July 1, 2021. ABIM Governance members help define the breadth of knowledge of Board-certified physicians, provide perspective on trends and scope of their discipline and collaborate with peers to...